Masafumi Kitakaze

39.5k total citations · 1 hit paper
474 papers, 19.4k citations indexed

About

Masafumi Kitakaze is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Masafumi Kitakaze has authored 474 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 266 papers in Cardiology and Cardiovascular Medicine, 111 papers in Molecular Biology and 100 papers in Pathology and Forensic Medicine. Recurrent topics in Masafumi Kitakaze's work include Cardiac Ischemia and Reperfusion (95 papers), Cardiovascular Function and Risk Factors (79 papers) and Heart Failure Treatment and Management (60 papers). Masafumi Kitakaze is often cited by papers focused on Cardiac Ischemia and Reperfusion (95 papers), Cardiovascular Function and Risk Factors (79 papers) and Heart Failure Treatment and Management (60 papers). Masafumi Kitakaze collaborates with scholars based in Japan, United States and China. Masafumi Kitakaze's co-authors include Tetsuo Minamino, Masatsugu Hori, Koichi Node, Seiji Takashima, Masanori Asakura, Hiroshi Asanuma, Shoji Sanada, Yulin Liao, Kazuo Komamura and Issei Komuro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Masafumi Kitakaze

465 papers receiving 19.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy

2002 590 citations Masanori Asakura, Masafumi Kitakaze et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masafumi Kitakaze Japan	74	8.2k	6.1k	3.8k	3.1k	2.8k	474	19.4k
Masatsugu Hori Japan	91	11.3k 1.4×	10.7k 1.8×	3.1k 0.8×	5.4k 1.7×	3.0k 1.1×	537	33.2k
Hiroyuki Tsutsui Japan	75	11.7k 1.4×	7.1k 1.2×	2.0k 0.5×	2.8k 0.9×	3.3k 1.2×	645	22.4k
Charles Steenbergen United States	72	4.9k 0.6×	7.4k 1.2×	5.7k 1.5×	1.9k 0.6×	2.4k 0.8×	206	16.5k
Naranjan S. Dhalla Canada	64	8.8k 1.1×	8.5k 1.4×	3.9k 1.0×	1.6k 0.5×	2.7k 1.0×	596	18.2k
Wilson S. Colucci United States	97	21.7k 2.6×	9.5k 1.6×	2.7k 0.7×	4.3k 1.4×	4.5k 1.6×	319	32.8k
Gary D. Lopaschuk Canada	93	14.1k 1.7×	16.4k 2.7×	3.7k 1.0×	4.0k 1.3×	10.3k 3.7×	378	33.0k
Heinrich Taegtmeyer United States	68	7.6k 0.9×	7.5k 1.2×	1.5k 0.4×	2.4k 0.8×	4.6k 1.6×	251	16.7k
Hisayoshi Fujiwara Japan	66	6.6k 0.8×	4.4k 0.7×	2.0k 0.5×	3.8k 1.2×	929 0.3×	391	15.2k
Walter J. Koch United States	97	13.0k 1.6×	22.1k 3.6×	2.4k 0.6×	2.7k 0.9×	3.5k 1.3×	507	32.3k
Tetsuji Miura Japan	58	4.1k 0.5×	4.1k 0.7×	3.5k 0.9×	1.5k 0.5×	1.7k 0.6×	393	12.7k

Countries citing papers authored by Masafumi Kitakaze

Since Specialization

Citations

This map shows the geographic impact of Masafumi Kitakaze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafumi Kitakaze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafumi Kitakaze more than expected).

Fields of papers citing papers by Masafumi Kitakaze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafumi Kitakaze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafumi Kitakaze. The network helps show where Masafumi Kitakaze may publish in the future.

Co-authorship network of co-authors of Masafumi Kitakaze

This figure shows the co-authorship network connecting the top 25 collaborators of Masafumi Kitakaze. A scholar is included among the top collaborators of Masafumi Kitakaze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafumi Kitakaze. Masafumi Kitakaze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Baihe, Haiqiong Liu, Minjun Chen, et al.. (2024). A novel function of claudin-5 in maintaining the structural integrity of the heart and its implications in cardiac pathology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(6). 167274–167274. 6 indexed citations

Tsukamoto, Osamu, Takuya Hasegawa, Ken Matsuoka, et al.. (2024). Relative B-Type Natriuretic Peptide Deficiency May Exist in Diastolic Dysfunction in Subclinical Population. Circulation Reports. 6(5). 151–160. 1 indexed citations

Tsukamoto, Osamu, Takuya Hasegawa, Ken Matsuoka, et al.. (2021). Lower B-Type Natriuretic Peptide Levels Predict Left Ventricular Concentric Remodelling and Insulin Resistance. ESC Heart Failure. 9(1). 636–647. 8 indexed citations

Yoshida, Akemi, Hatsue Ishibashi‐Ueda, Naoaki Yamada, et al.. (2013). Direct Comparison of the Diagnostic Capability of Cardiac Magnetic Resonance and Endomyocardial Biopsy in Patients with Heart Failure. European Journal of Heart Failure. 15(2). 166–175. 50 indexed citations

Sumi, Eriko, Toshinori Murayama, Masafumi Kitakaze, et al.. (2011). A Multi-institutional Descriptive Study on the Methods of Subject Recruitment for Clinical Trials. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 42(1). 27–31.

Xuan, Wanling, Yulin Liao, Baihe Chen, et al.. (2011). Detrimental effect of fractalkine on myocardial ischaemia and heart failure. Cardiovascular Research. 92(3). 385–393. 70 indexed citations

Yokoyama, Hiroyuki, Masataka Watanabe, Yosuke Nishihata, et al.. (2010). Patients with FPE Showed Fluid Redistribution, and Rapidly Improved of Condition by Initial Treatment with NIV. Circulation. 74. 475.

Ohara, Takahiro, Tetsuo Kamiishi, Satoshi Nakatani, et al.. (2008). Acute myocardial infarction due to thrombosis in the right sinus of Valsalva in a young woman. 40(8). 724–727.

Tsukamoto, Osamu, Masanori Asakura, Jiyoong Kim, et al.. (2006). Abstract 2370: Brain Natriuretic Peptide Enhances Adiponectin Production in Adipocytes. Circulation. 114(6). 1267–76. 2 indexed citations

10.

Wakeno, Masakatsu, Tetsuo Minamino, Osamu Seguchi, et al.. (2006). Long-Term Stimulation of Adenosine A2b Receptors Begun After Myocardial Infarction Prevents Cardiac Remodeling in Rats. Circulation. 114(18). 1923–1932. 84 indexed citations

11.

Myoishi, Masafumi & Masafumi Kitakaze. (2005). [A role of magnesium: magnesium in the therapy for cardiovascular diseases].. PubMed. 15(2). 265–70. 4 indexed citations

12.

Hashimoto, Shuji, Satoshi Nakatani, Izuru Nakasone, et al.. (2004). [Usefulness of conscious sedation with midazoram during transesophageal echocardiographic examination].. PubMed. 44(5). 195–200. 2 indexed citations

13.

Fukushima‐Uesaka, Hiromi, Kimie Sai, Keiko Maekawa, et al.. (2004). Genetic Variations of the AHR Gene Encoding Aryl Hydrocarbon Receptor in a Japanese Population. Drug Metabolism and Pharmacokinetics. 19(4). 320–326. 9 indexed citations

14.

Murayama, Norie, Akiko Soyama, Yoshiro Saito, et al.. (2004). Six Novel Nonsynonymous CYP1A2 Gene Polymorphisms: Catalytic Activities of the Naturally Occurring Variant Enzymes. Journal of Pharmacology and Experimental Therapeutics. 308(1). 300–306. 71 indexed citations

15.

Ogita, Hisakazu, Koichi Node, & Masafumi Kitakaze. (2003). The Role of Estrogen and Estrogen-Related Drugs in Cardiovascular Diseases. Current Drug Metabolism. 4(6). 497–504. 12 indexed citations

16.

Takashima, Seiji, Masafumi Kitakaze, Masanori Asakura, et al.. (2002). Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proceedings of the National Academy of Sciences. 99(6). 3657–3662. 292 indexed citations

17.

Takemoto, Masao, Koichi Node, Hironori Nakagami, et al.. (2001). Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. Journal of Clinical Investigation. 108(10). 1429–1437. 405 indexed citations

18.

Node, Koichi, et al.. (2000). IS174 Inhibition of Cardiomyocyte Hypertrophy by Estrogen. Japanese Circulation Journal-english Edition. 64. 174. 2 indexed citations

19.

Ahmet, Ismayil, Yoshiki Sawa, Motonobu Nishimura, et al.. (2000). Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning. The Annals of Thoracic Surgery. 70(3). 901–905. 5 indexed citations

20.

Sakata, Yasuhiko, Kazuhisa Kodama, Masafumi Kitakaze, et al.. (1997). Different Mechanisms of Ischemic Adaptation to Repeated Coronary Occlusion in Patients With and Without Recruitable Collateral Circulation. Journal of the American College of Cardiology. 30(7). 1679–1686. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact